发明名称 ANTIBODY FORMULATIONS
摘要 This invention relates to a shear and temperature stable antibody formulations that are more stable than compared to a standard formulation (such as 30 mM citrate, 100 mM NaCl, pH 6.5). The present invention's shear and temperature stable antibody formulations show reduced precipitation when subjected to stress conditions but the standard formulation had aggregated. This result was unpredictable because thermodynamically the two formulations are similar as seen by their DSC (differential scanning calorimeter) profiles.
申请公布号 US2015158951(A1) 申请公布日期 2015.06.11
申请号 US201514625881 申请日期 2015.02.19
申请人 GLAXOSMITHKLINE LLC 发明人 BRISBANE Charlene E.;KETKAR Amol Sharad;LASHMAR Ulla Tove
分类号 C07K16/28 主分类号 C07K16/28
代理机构 代理人
主权项 1. An method of treating an autoimmune disease in a human subject comprising administering an anti-CD20 antibody formulation comprising an anti-CD20 antibody present in an amount of 20-300 mg/ml, wherein the formulation further comprises 10 to 100 mM sodium acetate, 25 to 100 mM sodium chloride, 0.5 to 5% arginine free base, 0.02 to 0.2 mM EDTA, 0.01 to 0.2% polysorbate 80 and adjusted to pH 5.0 to 7.0.
地址 Wilmington DE US